Clinical Trials Logo

Clinical Trial Summary

The primary purpose of the protocol is to use next generation sequencing to identify pathogenic variants in genes involved in very rare skin diseases.

The secondary purpose will be to study the genotype-phenotype correlation in order to re-evaluate the classification of these disorders. This work could help in the understanding of the physiopathology of very rare skin disorders.


Clinical Trial Description

n/a


Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


NCT number NCT02509650
Study type Observational
Source University Hospital, Strasbourg, France
Contact Salima EL CHEHADEH, MD
Phone 33.3.88.12.81.20
Email salima.elchehadeh@chru-strasbourg.fr
Status Recruiting
Phase N/A
Start date September 2015
Completion date February 2018